论文部分内容阅读
Objective: To study the effect of RFTVR and CO2 laser on the improvement of symptoms, QOL and vas of patients with early laryngeal cancer. Methods: In this study, 120 patients with laryngeal cancer diagnosed and treated from January 2015 to December 2016 were taken as research objects. All patients were randomly divided into observation group and control group, 60 patients in each group. Patients in observation group were treated with RFTVR, and patients in control group were treated with new-type fiber-optic CO2 laser. The patients in the two groups were treated with cisplatin injection. The differences of perioperative indexes, swallowing function, pronunciation function, survival period, QOL score and VAS score between the two groups were compared. Results: There was no significant difference in the amount of intraoperative bleeding, operation time and hospitalization time between the two groups (P > 0.05); the correct swallowing of the observation group was significantly higher than that of the control group. After treatment, jitter, shimmer and HNR of the two groups were significantly improved, and jitter and shimmer of the observation group were significantly lower than that of the control group, and HNR was significantly higher than that of the control group (P < 0.05) The QOL score and VAS score of the two groups were significantly improved, and the QOL score of the observation group was significantly higher than that of the control group and the VAS score was significantly lower than that of the control group (P < 0.05); the total survival period and tumor free survival period of the observation group were significantly higher than that of the control group. Conclusion: Compared with CO2 laser treatment, the swallowing function and voice function of patients treated by low temperature plasma radiofrequency ablation were significantly improved, and the life quality of patients was significantly improved by prolonging the survival period of patients..